Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MindBio Therapeutics Corp.
C.MBIO
Healthcare
Biotechnology
MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic microdosing treatments for mental health conditions. MindBio has obtained government and regulatory approvals for at-home LSD microdosing in clinical trials, making it the only organization in the world to do so.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:MBIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on May 16, 2024 10:33am
Buzz on the Bullboards: Major developments amidst market dynamics
Several TSX-listed companies are making headlines with significant updates, strategic movements and quarterly reports.
read article.
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 14, 2024 10:55pm
The writing is on the wall
What today's news release left out is the game plan of Mindbio becoming Nazdaq listed through this deal with Enveric ... Mindbio needed a clean structured Psych company already listed and they
...more
IAMGOLD Publishes 17th Annual Sustainability Report and Inaugural Tailings Management Report
posted May 17, 2024 9:00am by
IAMGOLD Corp
-
|
"IAMGOLD is dedicated to fostering sustainable practices that benefit communities, minimize environmental impacts, and uphold the highest standards of business integrity," said Renaud Adams, President and Chief Executive Officer of IAMGOLD. "The 2023 Sustainability Report marks the 17th year of annual reporting for IAMGOLD on the sustainability topics that are most material to our stakeholders and ...read more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 14, 2024 11:34am
RE:Why Would Enveric Do This?
This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this particular formulation was in looking to do an FIH (first in human
...more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 14, 2024 10:03am
Why Would Enveric Do This?
The potential in this is extraordinary for both companies. I would expect that the reasons for Enteric entering into an agreement like this is that they have a much faster path to clinical trials for
...more
(8)
•••
RocketRed777
X
View Profile
View Bullboard History
Post by
RocketRed777
on May 14, 2024 9:53am
ENVERIC BIOSCIENCES SIGNS $66.5 MILLION
Mindbio signs term sheet for Enveric psilocin prodrugs 2024-05-14 09:35 ET - News Release Shares issued 135,047,305 MBIO Close 2024-05-13 C$ 0.055 Mr. Justin Hanka reports
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 14, 2024 8:11am
New Press Release - Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of...
read article.
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 14, 2024 7:02am
Interim Financials MD&A
https://www.sedarplus.ca/csa-party/viewInstance/resource.html?node=W2713&drmKey=f15a810d73e220dc&drr
...more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 06, 2024 9:18pm
Grant Money
The following is a link identifying the source of some of the money that was used to kickstart the current study on the benefits of microdosing LSD for advanced stage cancer patients. https://www.hrc
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 03, 2024 1:04pm
Nazdaq
If I were Justin I'd approach the same group that took MindMed to the Naz ... they've been very successful very liquid and very much in the investor line of sight always ... this sideways
...more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 03, 2024 11:34am
RE:RE:Where does the money come from?
Absolutely true, Sleepydog! Mindbend has been at this for a little over 4 years which would explain the "current" difference in market cap. Being an American entity where 95% of their
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Post by
Sleepydog24
on May 03, 2024 12:40am
Doctors and Scientists
The group of Doctors and Scientists behind this have simply amazing backgrounds and track records ... as Smoky said the money is being put forward through grants and other areas because of the
...more
(2)
•••
Sleepydog24
X
View Profile
View Bullboard History
Comment by
Sleepydog24
on May 03, 2024 12:31am
RE:Where does the money come from?
Amazing info you provide Smoky ... I feel this is going to be trading on the Naz and be the twin of MindMed which is close to a $Billion marketcap Canadian... both at the same stages in clinical
...more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 02, 2024 10:44am
Where does the money come from?
MBIO has to have significant research connections to move forward as quickly as they have been in branching out from Phase 1 to Phase 2 trials and already forecasting Phase 3 trials. The researchers
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 02, 2024 4:01am
New Press Release - MindBio Therapeutics Scientists Present Landmark Women's Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
VANCOUVER, BC / ACCESSWIRE / May 2, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a clinical stage biopharma company pioneering microdosing treatments for mental health conditions showcases Dr Rachael Sumner, presenting MindBio's landmark women's...
read article.
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Comment by
Smokey1958
on May 01, 2024 10:16pm
RE:CEO
I'll add another of the following to the latest naysayer on CEO: * liabilities will ALWAYS be higher than assets for a startup that has yet to make revenue. Junior mining companies have
...more
(430)
•••
Smokey1958
X
View Profile
View Bullboard History
Post by
Smokey1958
on May 01, 2024 4:02pm
CEO
To the naysayers on MBIO CEO ....you know who you are! * LSD has four isomers so already you're dealing with different forms * proprietary can and does involve the process not just the end result
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project